How Mushrooms Work as Food and Medicine

Mushrooms contain compounds that interact with your immune system, digestion, and inflammation in measurable ways. The most studied of these are beta-glucans (a type of fiber that triggers immune cells), polysaccharides (complex carbohydrates), and ergothioneine (an antioxidant found almost nowhere else in food). When you eat mushrooms—whether fresh button mushrooms or concentrated extracts—these compounds enter your bloodstream and bind to receptors on immune cells, signaling them to increase or decrease activity depending on what your body needs.

The difference between eating a mushroom and taking a mushroom supplement matters. A fresh mushroom is mostly water and fiber; a dried extract concentrates the active compounds 5 to 10 times over. This is why a clinical trial uses extract, not fresh mushrooms—the dose is controlled and measurable. But it also means the effect size in a trial may not match what you experience eating mushrooms as food, where the dose is lower and mixed with other nutrients.

Not all mushroom species have the same compounds. Shiitake, maitake, reishi, and cordyceps each contain different ratios of beta-glucans and other molecules. This is why research on one species does not automatically explore to another, and why a product labeled "mushroom blend" may or may not contain enough of any single species to produce the effect shown in studies.

Key Takeaways

  • Mushrooms contain beta-glucans and polysaccharides that set up immune cells in ways measurable in blood tests and cell cultures, but human trials showing disease prevention or treatment remain limited.
  • Most human evidence comes from observational studies (people who eat mushrooms tend to have lower disease rates) rather than randomized trials, so cause and effect are not yet proven.
  • Concentrated extracts contain 5 to 10 times more active compounds than fresh mushrooms, which is why clinical trials use extracts but the real-world effect of eating mushrooms may be smaller.
  • Different mushroom species have different compounds; shiitake, maitake, reishi, and cordyceps are not interchangeable, and "mushroom blend" products may not contain enough of any one type to match trial doses.
  • Mushrooms are safe for most people as food, but extracts can interact with blood thinners and immunosuppressants, and should not replace medical treatment for serious illness.

Immune Function — What the Research Shows

The strongest evidence for mushrooms involves immune cell set up. In laboratory studies, beta-glucans from shiitake and maitake mushrooms bind to receptors on macrophages and natural killer cells, causing them to increase production of cytokines (signaling molecules that coordinate immune response). This effect is reproducible and happens at doses achievable through diet or supplementation.

Human trials are smaller and less conclusive. A 2021 meta-analysis in Nutrients found that mushroom extracts modestly increased natural killer cell activity in people with cancer undergoing chemotherapy, but the studies were short (weeks to months) and most involved fewer than 100 people. A 2020 randomized trial in Nutrients showed that maitake extract increased antibody response to the flu vaccine in older adults, but the effect size was small and the study lasted only 8 weeks. Neither trial showed that mushroom use prevented infection or reduced disease severity in real-world conditions.

Observational data—studies tracking what people eat and what diseases they develop—show that people who eat mushrooms regularly have lower rates of certain cancers and infections. But these studies cannot prove mushrooms caused the protection; people who eat mushrooms may also exercise more, eat more vegetables, or have other healthy habits. Randomized trials are needed to separate mushroom effects from lifestyle.

Inflammation and Chronic Disease

Mushroom compounds reduce markers of inflammation in blood tests. A 2019 trial in Molecular Nutrition & Food Research found that people taking maitake extract for 12 weeks had lower levels of TNF-alpha and IL-6 (two inflammatory cytokines linked to heart disease and arthritis). A 2018 study in Phytotherapy Research showed similar results with reishi extract in people with metabolic syndrome.

These changes are real—inflammation markers dropped measurably—but it is unclear whether lower markers translate to fewer heart attacks, less arthritis progression, or longer life. No long-term trial has tracked whether mushroom users develop fewer chronic diseases over years or decades. The studies that exist are short (weeks to months), involve small groups, and measure blood markers rather than actual health outcomes.

One exception is observational data on mushroom consumption and cancer risk. Multiple large studies in Asia and Europe found that people eating mushrooms 1 to 3 times per week had 10 to 15 percent lower rates of breast, prostate, and colorectal cancer compared to those eating mushrooms rarely or never. The effect was consistent across studies, but again, this is association, not proof of cause. People in these studies who ate mushrooms also tended to eat more vegetables overall and have other protective habits.

Gut Health and Digestion

Mushrooms are a source of beta-glucans and chitin (a fiber that humans cannot digest), both of which feed beneficial bacteria in the colon. In test-tube studies, mushroom extracts increase the growth of Lactobacillus and Bifidobacterium species, bacteria associated with lower inflammation and better immune function. A 2022 study in Microorganisms found that people taking shiitake extract for 4 weeks had increased Bifidobacterium counts and lower fecal markers of inflammation.

The practical significance of this is still unclear. Increasing Bifidobacterium counts sounds beneficial, but no trial has shown that mushroom-induced increases in these bacteria prevent disease or improve symptoms in people with irritable bowel syndrome, inflammatory bowel disease, or other digestive conditions. Mushrooms may support a healthy microbiome as part of a diet high in vegetables and fiber, but they are not a treatment for existing gut disease.

Cognitive Function and Aging

Reishi and lion's mane mushrooms contain compounds (polysaccharides and hericenones) that stimulate nerve growth factor (NGF) production in animal studies. NGF is a protein that supports the survival and growth of neurons, and low NGF is associated with cognitive decline and Alzheimer's disease. A 2021 trial in Phytotherapy Research found that people taking lion's mane extract for 16 weeks showed modest improvements on cognitive tests compared to placebo, but the study involved only 80 people and lasted only 4 months.

No long-term trial has tested whether mushroom use slows cognitive decline or reduces Alzheimer's risk in aging populations. The animal evidence is encouraging—lion's mane extract improved memory in mice with induced cognitive impairment—but animal models do not always predict human outcomes. Until larger, longer human trials are completed, mushrooms should be viewed as a potential support for brain health, not a treatment or prevention for dementia.

Safety and Drug Interactions

Mushrooms are safe as food for most people. Allergic reactions are rare, and even high doses of mushroom extracts cause few side effects in short-term trials. The main exceptions are people taking blood thinners (warfarin, apixaban) or immunosuppressants (for transplant or autoimmune disease), because mushroom compounds can enhance anticoagulation or amplify immune suppression. If you take these medications, discuss mushroom supplements with your doctor before starting.

Mushroom extracts sold as supplements are not regulated the same way as drugs. The FDA does not review them for safety or potency before sale, and testing by independent labs shows that some products contain less active compound than the label claims, while others contain contaminants like heavy metals or mold toxins. If you choose to use a mushroom supplement, look for products tested by NSF International or USP (United States Pharmacopeia), which verify label claims and screen for contaminants.

Mushrooms are not a replacement for medical treatment. If you have cancer, heart disease, diabetes, or another serious illness, mushroom supplements should complement, not replace, the care your doctor recommends. Some mushroom compounds may interact with chemotherapy or other medications in ways not yet fully understood.

Which Mushrooms Have the Most Evidence

Maitake has the most human trial data, with studies showing immune cell set up and modest improvements in antibody response to vaccines. Most trials used standardized extracts containing 20 to 30 percent beta-glucans.

Shiitake appears in fewer human trials but shows similar immune effects in laboratory studies. One observational study linked regular shiitake consumption to lower cancer risk, but this was not a controlled trial.

Reishi has evidence for reducing inflammation markers and improving sleep quality in small trials, but no large randomized trials have tested whether it prevents disease. Most studies used extracts standardized to 10 to 30 percent polysaccharides.

Lion's mane has the most promising evidence for cognitive function, but only one published human trial exists. Animal studies are encouraging, but human data are limited.

Cordyceps are marketed for energy and athletic performance, but human trials are sparse and mostly small. One study found modest improvements in oxygen uptake during exercise, but the effect was small and the study involved only 20 people.

Frequently Asked Questions

Can eating fresh mushrooms give me the same benefits as supplements?

Fresh mushrooms contain the same active compounds as extracts, but in much lower concentrations. A cup of fresh shiitake has roughly 1 to 2 grams of beta-glucans; a clinical trial dose is often 5 to 10 grams of extract. You would need to eat several cups of mushrooms daily to match a trial dose. As food, mushrooms are nutritious and may support health as part of a varied diet, but they are not equivalent to the concentrated doses used in research.

Do mushroom supplements prevent cancer?

Observational studies show that people who eat mushrooms regularly have lower cancer rates, but this does not prove mushrooms prevent cancer. No randomized trial has tested whether mushroom supplements reduce cancer risk in healthy people. If you have a history of cancer or are at high risk, discuss mushroom use with your oncologist, as some compounds may interact with treatment.

Are mushroom supplements safe to take long-term?

Short-term use (weeks to months) is safe for most people. Long-term safety data are limited because few trials last longer than a few months. If you take blood thinners or immunosuppressants, consult your doctor before starting mushroom supplements, as they may amplify these effects.

What does "standardized" mean on a mushroom supplement label?

Standardized means the product is tested to contain a specific percentage of an active compound, usually beta-glucans or polysaccharides. A label saying "standardized to 30% beta-glucans" means each dose contains that percentage. Non-standardized products may vary widely in potency. Standardized extracts are more reliable for matching the doses used in clinical trials.

Can I take mushroom supplements if I am on chemotherapy?

Some mushroom compounds may enhance immune set up in ways that interact with chemotherapy or immunotherapy. Do not start mushroom supplements during cancer treatment without discussing it with your oncologist first. Some compounds may be beneficial alongside certain treatments, but this requires medical guidance specific to your situation.